Secor Capital Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-36,471
| Closed | -$1.92M | – | 464 |
|
|
2018
Q1 | $1.92M | Buy |
+36,471
| New | +$1.92M | 0.16% | 179 |
|
|
2017
Q3 | – | Sell |
-45,221
| Closed | -$1.53M | – | 396 |
|
|
2017
Q2 | $1.53M | Buy |
+45,221
| New | +$1.53M | 0.14% | 176 |
|
|
2016
Q4 | – | Sell |
-64,797
| Closed | -$2.04M | – | 436 |
|
|
2016
Q3 | $2.04M | Buy |
64,797
+10,906
| +20% | +$344K | 0.22% | 116 |
|
|
2016
Q2 | $1.43M | Buy |
+53,891
| New | +$1.43M | 0.18% | 146 |
|
|
2016
Q1 | – | Sell |
-11,108
| Closed | -$444K | – | 584 |
|
|
2015
Q4 | $444K | Buy |
+11,108
| New | +$444K | 0.13% | 234 |
|
|
2015
Q2 | – | Sell |
-12,430
| Closed | -$357K | – | 453 |
|
|
2015
Q1 | $357K | Buy |
+12,430
| New | +$357K | 0.14% | 270 |
|
|
2014
Q2 | – | Sell |
-14,831
| Closed | -$375K | – | 256 |
|
|
2014
Q1 | $375K | Sell |
14,831
-306
| -2% | -$7.74K | 0.18% | 205 |
|
|
2013
Q4 | $348K | Buy |
+15,137
| New | +$348K | 0.14% | 245 |
|